JFG
RPRX icon

Jefferies Financial Group’s Royalty Pharma RPRX Stock Holding History

Jefferies Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-137,000
Closed -$4.16M – 1817
2024
Q1 		$4.16M Sell
137,000
-30,814
-18% -$908K 0.04% 354
2023
Q4 		$4.71M Buy
167,814
+144,414
+617% +$3.97M 0.03% 422
2023
Q3 		$635K Sell
23,400
-95,330
-80% -$2.83M 0.01% 977
2023
Q2 		$3.65M Buy
118,730
+92,202
+348% +$3.12M 0.03% 448
2023
Q1 		$956K Sell
26,528
-5,750
-18% -$213K 0.01% 912
2022
Q4 		$1.28M Buy
+32,278
New +$1.35M 0.01% 800

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jefferies Financial Group's RPRX Position: Q2 2024 in Review

Jefferies Financial Group sold out of Royalty Pharma (RPRX) in Q2 2024, closing a stake of 137,000 shares — an estimated $4.16M sold.

Jefferies Financial Group first reported a position in RPRX in Q4 2022 and held it in 6 quarters. The position peaked at $4.71M in Q4 2023. 378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • Jefferies Financial Group reported no remaining Royalty Pharma position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 137,000 Royalty Pharma shares in Q2 2024, an estimated $4.16M.
  • Jefferies Financial Group first reported a position in Royalty Pharma in Q4 2022 and held it in 6 quarters.
  • Jefferies Financial Group's Royalty Pharma position peaked at $4.71M in Q4 2023.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.